Skip to content

Randomised controlled clinical compare the efficacy of arjunadiyog and calcium tablet in fracture.

Randomised controlled clinical trail to compare the efficacy of arjunadiyog and calcium tablet in kanda bhagna - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075267
Enrollment
60
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Tilak Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of long bone Fracture of upper and lower limb will be selected Patients of either sex will be selected Patients of age group of 18 onwards will be selected

Exclusion criteria

Exclusion criteria: Patients with a history of Pathological Fracture, Nonunion will be excluded. Patients with the localized defects like, Solitary bone cyst, Metastatic tumour will be excluded. Patients with acquired anomalies like Osteomyelitis, RA. will be excluded. Compound fracturesin which complicationslike injury to the blood vessels or nerves are excluded All fractures, except upper and lower limb will be excluded.

Design outcomes

Primary

MeasureTime frame
Decrease in Shool, Shotha and normal range of serum alkaline phosphateTimepoint: 30 days

Secondary

MeasureTime frame
Decrease in Shool, Shotha and normal range of serum alkaline phosphateTimepoint: 45 days

Countries

India

Contacts

Public ContactVaibhav Vijay Khondil

Tilak Ayurved Mahavidyalaya

nalawadenitin54@yahoo.com9822522905

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026